They are frequently admired for their antioxidant and anti-inflammatory benefits that contribute positively towards disease prevention
Several Indian companies are preparing to enter the market: Alkem Laboratories has started clinical trials for semaglutide and plans to launch close to patent expiration in March 2026. Biocon is developing its own version of Wegovy and aims to be one of the early players in the market, targeting a launch in 2026 or shortly after
While early data is promising and many anticipate that retatrutide may soon be available by prescription through legitimate medical channels, it is still in phase 3 clinical trials and has not been approved by the FDA for prescription use or sale
Beacon Research Solutions provides research grade peptides and supporting documentation, while also equipping independent healthcare providers, including physicians, functional medicine practices, and dietitians, with education and resources to navigate a space thats often confusing
It is important to note that semaglutide GLP-1 injections are not a stand-alone treatment for weight loss
Your doctor might also recommend trying another medication